| Mark Lovell, LCSW | |
|
509 N Cedar Ave, Cookeville, TN 38501-1707 | |
| (931) 520-8435 | |
| (931) 372-7225 |
| Full Name | Mark Lovell |
|---|---|
| Gender | Male |
| Speciality | Clinical Social Worker |
| Experience | 20 Years |
| Location | 509 N Cedar Ave, Cookeville, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902949159 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 4857 (Tennessee) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Personal Development Center, Inc. | 5496768855 | 8 |
News Archive
OphthaliX Inc., a clinical-stage company focused on developing therapeutic products for the treatment of ophthalmic disorders and a subsidiary of Can-Fite BioPharma Ltd., announced today it has signed a definitive agreement to acquire Israel-based Improved Vision Systems Ltd. in a stock-for-stock transaction.
Trubion Pharmaceuticals, Inc. today announced the acceptance of two Phase 1 data presentations on SBI-087 (PF-05230895) at the 2010 annual congress of the European League Against Rheumatism (EULAR) in Rome, Italy. Presentations will include promising data from a Phase 1 study of SBI-087 for the treatment of rheumatoid arthritis (RA) and a Phase 1 study of SBI-087 for the treatment of systemic lupus erythematosus (SLE). Copies of both abstracts are available at http://www.eular.org. SBI-087 is Trubion's next-generation CD20-directed small modular immunopharmaceutical (SMIP™) product candidate and is being developed in collaboration with Pfizer.
When you think of hip replacement surgery, you generally envision an older adult with painful osteoarthritis. But the procedure is also used for younger patients with juvenile idiopathic arthritis (JIA) whose joints have been severely damaged by the disease.
Fathers' extremely long working hours can be detrimental to their sons´ wellbeing. This is the key finding of a longitudinal study by Jianghong Li (senior researcher at the WZB Berlin Social Science Center) and four Australian co-authors, published in the Journal of Marriage and Family.
Australia's adult stem cell company, Mesoblast Limited, today announced that it had signed an agreement for production of specialised adult stem cells, known as Mesenchymal Precursor Cells (MPCs), to be used in human pilot clinical trials in patients with orthopaedic and cardiovascular diseases.
› Verified 2 days ago
| Entity Name | Personal Development Center, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942324884 PECOS PAC ID: 5496768855 Enrollment ID: O20071116000279 |
News Archive
OphthaliX Inc., a clinical-stage company focused on developing therapeutic products for the treatment of ophthalmic disorders and a subsidiary of Can-Fite BioPharma Ltd., announced today it has signed a definitive agreement to acquire Israel-based Improved Vision Systems Ltd. in a stock-for-stock transaction.
Trubion Pharmaceuticals, Inc. today announced the acceptance of two Phase 1 data presentations on SBI-087 (PF-05230895) at the 2010 annual congress of the European League Against Rheumatism (EULAR) in Rome, Italy. Presentations will include promising data from a Phase 1 study of SBI-087 for the treatment of rheumatoid arthritis (RA) and a Phase 1 study of SBI-087 for the treatment of systemic lupus erythematosus (SLE). Copies of both abstracts are available at http://www.eular.org. SBI-087 is Trubion's next-generation CD20-directed small modular immunopharmaceutical (SMIP™) product candidate and is being developed in collaboration with Pfizer.
When you think of hip replacement surgery, you generally envision an older adult with painful osteoarthritis. But the procedure is also used for younger patients with juvenile idiopathic arthritis (JIA) whose joints have been severely damaged by the disease.
Fathers' extremely long working hours can be detrimental to their sons´ wellbeing. This is the key finding of a longitudinal study by Jianghong Li (senior researcher at the WZB Berlin Social Science Center) and four Australian co-authors, published in the Journal of Marriage and Family.
Australia's adult stem cell company, Mesoblast Limited, today announced that it had signed an agreement for production of specialised adult stem cells, known as Mesenchymal Precursor Cells (MPCs), to be used in human pilot clinical trials in patients with orthopaedic and cardiovascular diseases.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mark Lovell, LCSW 6545 Bunker Hill Rd, Cookeville, TN 38506-7652 Ph: () - | Mark Lovell, LCSW 509 N Cedar Ave, Cookeville, TN 38501-1707 Ph: (931) 520-8435 |
News Archive
OphthaliX Inc., a clinical-stage company focused on developing therapeutic products for the treatment of ophthalmic disorders and a subsidiary of Can-Fite BioPharma Ltd., announced today it has signed a definitive agreement to acquire Israel-based Improved Vision Systems Ltd. in a stock-for-stock transaction.
Trubion Pharmaceuticals, Inc. today announced the acceptance of two Phase 1 data presentations on SBI-087 (PF-05230895) at the 2010 annual congress of the European League Against Rheumatism (EULAR) in Rome, Italy. Presentations will include promising data from a Phase 1 study of SBI-087 for the treatment of rheumatoid arthritis (RA) and a Phase 1 study of SBI-087 for the treatment of systemic lupus erythematosus (SLE). Copies of both abstracts are available at http://www.eular.org. SBI-087 is Trubion's next-generation CD20-directed small modular immunopharmaceutical (SMIP™) product candidate and is being developed in collaboration with Pfizer.
When you think of hip replacement surgery, you generally envision an older adult with painful osteoarthritis. But the procedure is also used for younger patients with juvenile idiopathic arthritis (JIA) whose joints have been severely damaged by the disease.
Fathers' extremely long working hours can be detrimental to their sons´ wellbeing. This is the key finding of a longitudinal study by Jianghong Li (senior researcher at the WZB Berlin Social Science Center) and four Australian co-authors, published in the Journal of Marriage and Family.
Australia's adult stem cell company, Mesoblast Limited, today announced that it had signed an agreement for production of specialised adult stem cells, known as Mesenchymal Precursor Cells (MPCs), to be used in human pilot clinical trials in patients with orthopaedic and cardiovascular diseases.
› Verified 2 days ago
Mrs. Karen Renee Ledbetter, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 377 Short St Ste C, Cookeville, TN 38501 Phone: 931-528-9399 Fax: 931-526-9300 | |
Frances M Kernea, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 753 Humble Dr Ste A, Cookeville, TN 38501 Phone: 931-783-2561 | |
Joelle Marlin, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 442 Neal St, Cookeville, TN 38501 Phone: 423-251-4072 | |
Robin D Gibson, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 1200 S Willow Ave, Cookeville, TN 38506 Phone: 931-432-4123 Fax: 931-432-5838 | |
Mr. Cosby Dale Dobson, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 121 S Dixie Ave, Cookeville, TN 38501 Phone: 931-528-2531 Fax: 931-526-7451 | |
Mary Gabbert, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1080 Neal St Ste 200, Cookeville, TN 38501 Phone: 193-152-0152 Fax: 931-223-0106 | |
Ms. Lisa A Lovell, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 509 N Cedar Ave, Cookeville, TN 38501 Phone: 931-520-8435 Fax: 931-372-7225 |